| 1 |
34904522 | Optimal pH 8.5 to 9 for the hydrolysis of vixotrigine and other basic substrates of carboxylesterase-1 in human liver microsomes. | 2022 Feb |
1 |
| 2 |
28126414 | Recent progress in the discovery of natural inhibitors against human carboxylesterases. | 2017 Mar |
1 |
| 3 |
28775293 | Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients. | 2017 Aug 3 |
2 |
| 4 |
27196064 | The Metabolism of Clopidogrel: CYP2C19 Is a Minor Pathway. | 2016 Dec |
1 |
| 5 |
25704243 | Carboxylesterase 1 c.428G>A single nucleotide variation increases the antiplatelet effects of clopidogrel by reducing its hydrolysis in humans. | 2015 Jun |
2 |
| 6 |
24512105 | Association between copy number variation losses and alcohol dependence across African American and European American ethnic groups. | 2014 May |
1 |
| 7 |
23111421 | The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response. | 2013 Jan |
2 |
| 8 |
23386702 | Reversible inhibition of human carboxylesterases by acyl glucuronides. | 2013 Apr |
3 |
| 9 |
19062296 | Comparison of benzil and trifluoromethyl ketone (TFK)-mediated carboxylesterase inhibition using classical and 3D-quantitative structure-activity relationship analysis. | 2009 Jan 1 |
1 |
| 10 |
17936933 | Human carboxylesterases and their role in xenobiotic and endobiotic metabolism. | 2007 |
1 |